|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0032854,
umls-concept:C0032961,
umls-concept:C0033011,
umls-concept:C0034656,
umls-concept:C0199176,
umls-concept:C0205484,
umls-concept:C0262926,
umls-concept:C1136254,
umls-concept:C1561558,
umls-concept:C2004062
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-10-28
|
|
pubmed:abstractText |
This study was undertaken to measure the impact of a single oral dose of cefetamet-pivoxil on pregnancy outcome in a population with substantial rates of low birth weight and high prevalence rates of maternal infections.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0002-9378
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
177
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
680-4
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9322642-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:9322642-Administration, Oral,
pubmed-meshheading:9322642-Adult,
pubmed-meshheading:9322642-Birth Weight,
pubmed-meshheading:9322642-Ceftizoxime,
pubmed-meshheading:9322642-Cervix Uteri,
pubmed-meshheading:9322642-Cost-Benefit Analysis,
pubmed-meshheading:9322642-Dose-Response Relationship, Drug,
pubmed-meshheading:9322642-Endometritis,
pubmed-meshheading:9322642-Female,
pubmed-meshheading:9322642-Fetal Death,
pubmed-meshheading:9322642-Gonorrhea,
pubmed-meshheading:9322642-Humans,
pubmed-meshheading:9322642-Infant, Newborn,
pubmed-meshheading:9322642-Kenya,
pubmed-meshheading:9322642-Neisseria gonorrhoeae,
pubmed-meshheading:9322642-Pregnancy,
pubmed-meshheading:9322642-Pregnancy Complications, Infectious,
pubmed-meshheading:9322642-Pregnancy Outcome,
pubmed-meshheading:9322642-Pregnancy Trimester, Third,
pubmed-meshheading:9322642-Prevalence,
pubmed-meshheading:9322642-Treponemal Infections
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Antimicrobial prophylaxis in pregnancy: a randomized, placebo-controlled trial with cefetamet-pivoxil in pregnant women with a poor obstetric history.
|
|
pubmed:affiliation |
World Health Organization Centre for Research and Training in Sexually Transmitted Diseases, Department of Medical Microbiology, University of Nairobi, Kenya.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
